Welcome to The Coolest Nicknames

Comments

Googlism comments

AGONIST is safe
AGONIST is a drug that causes a response
AGONIST is determined by both ke and the total receptor density of the tissue
AGONIST is usually 0
AGONIST is still bound to the ligand binding site
AGONIST is needed
AGONIST is far less common a term than its kin protAGONIST
AGONIST is usually scheduled to be taken when levodopa is administered as a matter of
AGONIST is a drug that is capable
AGONIST is the drug
AGONIST is a drug which combines with a receptor to initiate a response
AGONIST is a drug with affinity and efficacy an antAGONIST is a drug that has affinity but no efficacy
AGONIST is not present
AGONIST is known as the synergist
AGONIST is much stronger than the antAGONIST the AGONIST is known as the synergist the AGONIST is stretched and unable to develop maximum tension the
AGONIST is dedicated to open and honest intellectual discussion about a broad range of topics
AGONIST is started
AGONIST is now in progress in the us
AGONIST is pilocarpine
AGONIST is begun at the time of menstruation
AGONIST is much stronger than the antAGONIST
AGONIST is administered for 10 days or longer
AGONIST is a substance or drug that produces a maximal or nearly maximal response
AGONIST is a drug which acts at the same receptor as that of an AGONIST
AGONIST is glutamate; n
AGONIST is contracting
AGONIST is blocked
AGONIST is in presence of an antAGONIST
AGONIST is available to elicit a response by binding to the receptor
AGONIST is regarded as a
AGONIST is in accordance with new guidelines for the management of parkinson's disease
AGONIST is a molecule that shifts the equilibrium between the inactive and active states of a gpcr toward the active state
AGONIST is dedicated to open and intellectually honest debate
AGONIST is no longer relieving the symptoms
AGONIST is not changed
AGONIST is then followed by recovery of cell responsiveness
AGONIST is in accordance with new guidelines for the management of parkinson’s disease
AGONIST is in accordance with new guidelines for the management of parkinson?s disease
AGONIST is albuterol which is available generically
AGONIST is in ragnarock site
AGONIST is stretched and unable to develop maximum tension
AGONIST is contract to take the limb to the new range as the therapist aids this motion
AGONIST is en het mogelijk bij hoge dosis een vermindering van het bronchoprotectieve effect veroorzaakt
AGONIST is a type of drug which binds to the opioid receptors
AGONIST is continued until the administration of human chorionic gonadotropin
AGONIST is
AGONIST is one of the outlined treatment options in the nhlbi asthma
AGONIST is acting at a single receptor subtype
AGONIST is likely
AGONIST is a medication designed to act like dopamine
AGONIST is acting at a
AGONIST is one of the treatment options in the bts asthma guidelines at step 3
AGONIST is added
AGONIST is a molecule that binds receptor and fully induces post
AGONIST is and what they
AGONIST is another type of hormone therapy
AGONIST is that
AGONIST is given alone
AGONIST is as effective as the drug levodopa at relieving symptoms of the disease
AGONIST is lost resulting in the zero
AGONIST is that one can cease therapy
AGONIST is the relaxation of bronchial smooth muscle via the stimulation of beta2 receptors
AGONIST is nicotine
AGONIST is administered when there is very little full AGONIST available
AGONIST is given for three to six months
AGONIST is mildly stretched to increase the firing rate while the AGONIST is places into
AGONIST is inactivated
AGONIST is the most convenient for their
AGONIST is bound to the receptor
AGONIST is controversial
AGONIST is to be used for relief of acute asthma symptoms and that it can also be used before exercise
AGONIST is defined as "a role played by a muscle acting to cause a movement"
AGONIST is in addition to steroids; lazarus
AGONIST is likely to bind in
AGONIST is because it will cause firing to take place but will do so at a fairly slow rate
AGONIST is thought to suppress the stimulatory effects of tamoxifen on plasma estrogen levels
AGONIST is a variant peptide while the immunogenic peptide is the normal one
AGONIST is not l
AGONIST is sufficient to make the
AGONIST is energetically favoured